Kukita K
First Department of Surgery, Hokkaido University, School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1990 May;65(3):254-65.
The cytotoxic effect of the anticancer drug, Daunorubicin, combined with the anti human AFP horse antibody (Conjugate) on AFP-producing cells and non producing cells was studied in vitro. No different cytotoxic effects between the conjugate and the anticancer drug alone were observed on non-AFP-producing cells. On the other hand, the conjugate had a much stronger cytotoxic effect than the anticancer drug alone against AFP-producing cells when it was incubated for 24 hours, 5 x 10(-1) micrograms/ml as an anticancer concentration. The cytotoxicity of the conjugate is much stronger than of the comcrued effect of the anticancer drug and the anti AFP antibody (individually). The amount of AFP antibody used was very small. Therefore, the effect of the anticancer drug plus the small amount of AFP antibody was almost the same as the effect of anticancer drug alone. Under these conditions melting of nuclear material (cell death) was remarkable morphologically, and the intracellular anticancer concentration of the conjugate was seven times higher than that of the anticancer drug alone (p less than 0.05). In conclusion, the conjugate has more cytotoxic effect than the anticancer drug alone against AFP-producing hepatoma cells in optimal conditions.
在体外研究了抗癌药物柔红霉素与抗人甲胎蛋白马抗体(偶联物)联合作用于产生甲胎蛋白的细胞和不产生甲胎蛋白的细胞的细胞毒性作用。在不产生甲胎蛋白的细胞上,未观察到偶联物与单独使用抗癌药物之间有不同的细胞毒性作用。另一方面,当以5×10⁻¹微克/毫升作为抗癌浓度孵育24小时时,偶联物对产生甲胎蛋白的细胞的细胞毒性作用比单独使用抗癌药物强得多。偶联物的细胞毒性比抗癌药物和抗甲胎蛋白抗体(单独使用时)的联合作用强得多。所用甲胎蛋白抗体的量非常少。因此,抗癌药物加少量甲胎蛋白抗体的作用与单独使用抗癌药物的作用几乎相同。在这些条件下,核物质的溶解(细胞死亡)在形态学上很明显,并且偶联物的细胞内抗癌浓度比单独使用抗癌药物时高7倍(p小于0.05)。总之,在最佳条件下,偶联物对产生甲胎蛋白的肝癌细胞的细胞毒性作用比单独使用抗癌药物更强。